What W&I insurance is, why it's now routine in M&A, and how it raises the bar for FDD — insurers read your diligence and price cover on the strength of it.
A decade ago, Warranty & Indemnity (W&I) insurance was a niche product. Today it features in a large share of mid-market and upper-market M&A deals, and it has quietly raised the stakes for everyone doing diligence. The reason matters to anyone in Transaction Services: insurers will not underwrite a policy unless the diligence is thorough, and they read your reports — line by line, with their own advisers, before they commit capital. Understanding W&I therefore tells you why the quality bar on FDD has risen, why your work now has a second audience, and why sloppy diligence has consequences far beyond a single engagement. This article explains the product, walks through how a finding flows into cover, and shows what it all means for your job.
In a typical M&A deal, the seller gives the buyer a set of warranties — statements that the business is as described. The accounts are accurate; there is no undisclosed litigation; tax has been paid; there are no hidden liabilities. The seller sometimes also gives specific indemnities for known risks, promising to cover a defined exposure pound for pound. If a warranty turns out to be false and the buyer suffers a loss, the buyer can claim against the seller under the SPA.
W&I insurance is a policy that steps into that relationship. Instead of the buyer claiming against the seller, it claims against an insurer. The most common form is a buy-side policy: the buyer takes out cover and, if a warranty is breached, recovers from the insurer rather than chasing the seller. The seller's liability is effectively transferred to the policy, often shrinking to a token cap. The policy has its own architecture — a retention (an excess the buyer bears before cover kicks in), a cover limit, a premium, and a set of exclusions carving out what the insurer will not stand behind. That last element is where diligence and insurance meet, and it is the part TS professionals most need to understand.
The product solves a problem both sides feel acutely.
The result is a market where, particularly in private-equity-driven deals, W&I has gone from exotic to routine — and, crucially, so has the underwriting scrutiny that comes with it.
The mechanics matter. In a conventional deal, the SPA allocates risk through the warranties, indemnities, liability caps and the seller's covenants. With W&I in place, that allocation is partly rewired:
But — and this is the crucial point — the insurer only covers what has been properly disclosed and diligenced. Anything the buyer knew about, or should have known about through reasonable diligence, is typically excluded. Known issues do not disappear; they get carved out of cover and pushed back into the SPA as specific indemnities or price adjustments.
Rule of thumb: W&I transfers unknown risk, not known risk. A problem you find in diligence is not insured away — it is handed back to the deal team to price or indemnify. The policy covers the surprises, not the things you already saw coming.
Here is where Transaction Services comes directly into the frame. Before an insurer puts capital behind a policy, it runs its own underwriting process — and the centre of that process is your diligence. The insurer is, in effect, taking a view on the same risk the buyer is, and it forms that view largely by reading what you wrote.
The insurer's advisers will read the buy-side FDD report (and, on a vendor-led process, the vendor due diligence report) closely. They are asking:
Thin or scoped-out diligence leads to exclusions in the policy — the insurer simply refuses to cover areas it does not believe were examined. In a process built around a VDD report, the insurer leans heavily on that report's depth and the buyer's top-up work. Either way, the diligence is no longer read only by the deal team; it is read by an underwriter deciding whether to put millions of pounds at risk on the strength of it. That is a very different reader from the one most analysts imagine when they draft a finding.
Abstract principles land better with a concrete case. Suppose you are on the buy-side FDD for a software business and you examine revenue recognition. Here is how three different findings flow through to the policy.
| What diligence found | How it flows through | Effect on the buyer |
|---|---|---|
| Revenue recognition tested; policy sound; no issues | Area is covered as normal | Full W&I protection on revenue |
| A specific £1.2m of revenue recognised early on one contract — identified and quantified | Known issue → carved out of cover, handled in the SPA as a price adjustment or specific indemnity | Buyer priced it; not relying on insurance |
| Revenue scope narrow; recognition policy noted as "not tested in detail" | Insurer excludes revenue-recognition warranties from cover | Buyer exposed — no seller recourse, no insurance |
Look closely at the difference between rows two and three. In the second, thorough diligence found a real problem, quantified it, and the deal team handled it in the SPA — a good outcome. In the third, the absence of testing did not protect the buyer; it created a hole. The insurer will not cover an area the report describes as untested, so the buyer ends up with neither seller recourse (capped at £1) nor insurance. The uncomfortable lesson: an unexamined area is worse than a found problem, because a found problem gets priced while an unexamined one becomes an exposed blind spot.
Key insight: in a W&I deal, silence in your report is not neutral. An area you did not test does not stay open for later — it becomes an exclusion, and the buyer carries that risk uninsured.
This changes the standard you are held to.
| Without W&I | With W&I |
|---|---|
| Report read by deal team and advisers | Also read by insurer and its counsel |
| Scope gaps are the buyer's problem to weigh | Scope gaps become policy exclusions |
| Findings inform the SPA | Findings inform both the SPA and what's insurable |
| "Good enough" is an internal judgement | "Good enough" has an external underwriter's view |
The practical effect is that diligence has to be demonstrably thorough. The report must show its working: what was tested, how, against what evidence, and what was concluded. An underwriter cannot give credit for analysis they cannot see — if the procedure is not on the page, for their purposes it did not happen. The financial due diligence process becomes not just a tool for the buyer's decision, but a document that has to satisfy a sceptical third party who is pricing risk off it.
For the analyst and the team, W&I has tangible, day-to-day implications:
In short, W&I has turned diligence into a product with a second audience. That raises the bar — and makes good TS work more valuable, not less, because the quality of your report now directly shapes what the client can insure. It also subtly changes how a good team scopes an engagement: areas that a buyer might once have waved through on a tight timetable now carry a visible cost if left untested, because that gap will resurface as a policy exclusion. The insurer's presence, in effect, disciplines the scope conversation and gives the diligence team a concrete argument for doing the work properly.
Even experienced teams slip on the W&I dimension. Watch for these:
A sharp interviewer may ask: "How does W&I insurance affect the way we do diligence?" It is a great question precisely because it tests whether you see beyond the spreadsheet to the commercial chain your work sits in.
A strong answer:
"W&I transfers the seller's warranty risk to an insurer, but only for unknown risks that have been properly diligenced. That puts our reports in front of a second audience — the underwriter — who reads the FDD and any VDD report to decide what they'll cover. If our scope is thin or our findings are vague, the insurer carves those areas out as exclusions, and the buyer is left exposed with neither seller recourse nor insurance. If we find a specific issue, that becomes a known risk, so it's carved out of cover and handled in the SPA as an indemnity or a price adjustment. So W&I raises the quality bar: the diligence has to show its working, document what was and wasn't tested, and flag known issues cleanly. It makes thorough, well-evidenced diligence commercially valuable, because it directly affects what the client can actually insure."
That answer shows you understand the commercial chain from your analysis all the way to the insurance policy — exactly the kind of joined-up thinking that marks out a candidate who gets how deals really work. If you can add the distinction between a found issue (carved out, handled in the SPA) and an untested area (excluded, uninsured), you demonstrate a level of understanding most candidates never reach.
W&I insurance did not make diligence less important — it made it the load-bearing document in the deal. Your report now has to convince the buyer, satisfy the SPA lawyers, and stand up to an underwriter pricing millions of pounds of risk off its pages. Do that work well and you are not a cost centre on the deal; you are the reason the cover exists at all.
The Transaction Services Interview Programme (€119.99, one-time) includes a module on W&I insurance and the diligence quality bar it sets, so you can explain how a finding flows through to cover and exclusions, why known issues go back to the SPA, and why thoroughness is commercially valuable. Enrol today.
Hundreds of candidates prepared their interviews with this programme. Those who landed the role have one thing in common: they worked the cases before walking into the room.
